Various extracts from 30 medicinal plants were evaluated for their antiviral activity against influenza virus A/Puerto Rico/ 8/34 (H1N1) and cytotoxicity in MDCK cell culture. The plant material (30 g) was extracted with methanol (300 mL) at room temperature for 24 h, after which the methanolic extracts were filtered, evaporated, and subsequently lyophilized. Evaluation of the potential antiviral activity was conducted by a viral replication inhibition test. Among these medicinal plants, Tussilago farfara, Brassica juncea, Prunus armeniaca, Astragalus membranaceus, Patrinia villosa, and Citrus unshiu showed marked antiviral activity against influenza virus A/H1N1 at concentrations ranging from 0.15625 mg/mL to 1.25 mg/mL, 0.3125 mg/mL to 10 mg/mL, 5 mg/mL to 10 mg/mL, 0.625 mg/mL to 10 mg/mL, 0.625 mg/mL to 10 mg/mL, and 0.3125 mg/mL to 5 mg/mL, respectively. The extracts of Tussilago farfara showed cytotoxicity at concentrations greater than 2.5 mg/mL, whereas the other five main extracts showed no cytotoxicity at concentrations of 10 mg/mL. Taken together, the present results indicated that methanolic extracts of the six main plants might be useful for the treatment of influenza virus H1N1.
Introduction
Human influenza viruses consist of the three subgroups (A, B, and C). They are enveloped viruses with singlestranded RNA that made up of segments (Charles, 2002) . Three transmembrane proteins, the hemagglutinin (HA), the neuraminidase (NA) and the ion channel (M2) are embedded in the viral envelope (De . Influenza virus infects the mucous membranes of the upper respiratory tract and occasionally invades the lungs and secondary bacterial infection may occur in individuals (Park and Lee, 2005) . The respiratory disease caused by influenza A viruses is highly contagious for several animals including humans. Three influenza virus pandemics occurred in the last century, in 1918 , 1957 , and 1968 (Droebner et al., 2007 . The first and most devastating of the 20th century pandemic strains emerged in 1918 and caused twenty million deaths worldwide (Beigel and Bray, 2008) . M2 ion channel inhibitors, amantadine and rimantadine, have been widely used in prophylaxis of influenza virus infections. Neuraminidase inhibitors, zanamivir and oseltamivir, are effective in both prophylaxis and treatment of influenza A and B viruses. However, their utilization in clinic is further limited by the rapid emergence of resistant virus mutants. The needs for an inhaler device and the risk of bronchospasm limit the use of zanamivir. Oseltamivir is being used although the gastrointestinal effects and emergence of resistant variants in some treated populations have limited the use of this drug (Hurt et The aim of this study was to determine the antiviral activity of various medicinal plants against influenza A virus subtype H1N1.
Materials and Methods

Preparation of plant extracts
Medicinal plants were selected from Korean medicine book describing traditional medicines (Text Publishing Committee for Oriental Pharmacology, 2005). The list of the medicinal plants used in this study is shown in Table  1 .
Methanolic extracts of the medicinal plants tested were prepared according to the procedures previously described with modification (Kim et al., 2007; Shin et al., 2008) . Briefly, plant materials were extracted by using the method as described below. Dried and ground plant mate- C overnight and the frozen mass was then subsequently subjected to lyophilization. Each compound was dissolved in serum-free Eagle's minimum essential medium (MEM) with concentration of 100 mg/ mL. The solution was sterilized by filtration using membrane filter with 0.45 µm pore size and stored at 4 o C (Fig.  1 ).
Viruses and cells
Influenza A/Puerto Rico/8/34 (H1N1) was propagated in 10-day-old embryonated chicken eggs in approved biosafety level-2 facility. Madin-Darby canine kidney (MDCK) cells were routinely grown in maintenance medium consisting Eagle's minimum essential medium (MEM) supplemented with 10% heat inactivated fetal bovine serum (FBS), 100 U/mL penicillin and 0.1 mg/mL streptomycin. Virus growth medium for making virus pools and performing antiviral assays consisted of MEM with 0.3% Bovine Serum Albumin (BSA), 100 U/mL penicillin, 0.1 mg/mL streptomycin and 1 mg of N-tosyl-L-phenylalanine chloromethyl ketone (TPCK)-treated trypsin per mL.
Virus titration
Virus titration was performed by the end-point dilution method, using a 96-well microtitre plate with 6 wells per dilution and using 10-fold dilution method. The virus titer was estimated by cytopathic effect (CPE) of cells induced by viral infection and expressed as 50% tissue culture infectious doses (TCID 50 ). TCID 50 calculation was described by Reed and Muench method (Del Barrio and Parra, 2000) .
Antiviral activity assay
In vitro antiviral ability evaluation was performed by cytopathic effect reduction assay . MDCK cells were seeded on 96-well plate with 1. 
Cytotoxicity test
The maximum nontoxic concentration of each extract was determined based on cellular morphological alteration (Özçelik et al., 2009 ). MDCK cells were seeded at 1.5×10
4 cells in 96-well plate and incubated at 37 o C for 16 h. After incubation, MDCK cell monolayers were washed twice with 100 µL of PBS, and then exposed to 100 µL of media containing serially diluted extract of each sample and incubated for 48 h in 5% CO 2 incubator at 37 o C. At each sheet, controls without extracts were performed in all assays.
Results and Discussion
Different parts of 30 medicinal plants were tested for their antiviral activity and cytotoxicity. Of the extracts tested in this study, 6 major plants (Fig. 2) , Tussilago farfara, Brassica juncea, Prunus armeniaca, Astragalus membranaceus, Patrinia villosa, and Citrus unshiu, were found to have antiviral activity against influenza A/Puerto Rico/8/34 (H1N1) at a non-toxic concentration to the MDCK cell lines. The results of 6 major plant extracts tested against viruses are shown in Table 2 . The methanolic extract of Tussilago farfara was found to inhibit influenza virus at concentrations ranging from 1.25 mg/ mL to 0.15625 mg/mL. However, the extract has cytotox- icity at higher than 2.5 mg/mL. At a concentration lower than 10 mg/mL, the methanolic extracts of Brassica juncea, Prunus armeniaca, Astragalus membranaceus, Patrinia villosa, and Citrus unshiu showed no cytotoxicity to the MDCK cell. The extracts of Brassica juncea and Citrus unshiu presented antiviral effect at a concentration above 0.3125 mg/mL, respectively. Patrinia villosa extract was found to possess antiviral activity at the lowest concentration of 5 mg/mL. Examples were provided by the methanol extracts of Astragalus membranaceus and Patrinia villosa, which showed antiviral activity at the lowest concentration of 0.625 mg/mL, respectively. The oriental medicinal plants investigated here are used to treat respiratory ailment and to boost the body's immune system and digestion. In recent study, Tussilago farfara has found to have antioxidant activity ( The antiviral activity of crude plant extract should be detectable in at least two subsequent dilutions of the maximum non-toxic concentration to ensure that the activity is not directly correlated with the toxicity of the extract. Six major active extracts in this study were found to have antiviral activity after two subsequent dilutions. It is possible that the elucidation of active constituents in these plants may provide useful leads in the development of antiviral therapeutics. CPE, cytopathogenic effect. 
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